Eye Health News and Research

Latest Eye Health News and Research

Researchers identify brain processes in mice that shape different sensory perceptions

Scientists have long known that when sounds are faint or objects are seen through fog in the distance, repetition of these weak or ambiguous sensory “inputs” can result in different perceptions inside the same brain.

10 Dec 2015

New portable sensor can measure vitamin C levels in fluids that leak from the eye

An engineer and an ophthalmologist are developing a portable sensor that can quickly and inexpensively determine whether an eye injury is mild or severe. The device, called OcuCheck, measures levels of vitamin C in the fluids that coat or leak from the eye.

9 Dec 2015

Biotypes can identify distinct subgroups of psychosis

Three biomarker-based categories, called biotypes, outperformed traditional diagnoses, such as schizophrenia and bipolar disorder with psychosis, in sorting psychosis cases into distinct subgroups on the basis of brain biology, report researchers funded by the National Institutes of Health.

9 Dec 2015

Adverse environmental changes present potential health hazards to eyes

Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research at the Wilmer Eye Institute, Johns Hopkins University.

9 Dec 2015

Groundbreaking study establishes empirical biomarkers to aid in diagnosis, treatment of psychosis

In a groundbreaking study led by UT Southwestern Medical Center, a comprehensive set of empirical biomarkers has been established to aid in diagnosis and treatment of psychosis.

9 Dec 2015

UHCO's Pat Segu earns prestigious distinguished service award in vision care

The University of Houston College of Optometry's Pat Segu, O.D., was honored with a prestigious distinguished service award for the continued high quality of service she has demonstrated in the area of public health eye and vision care.

9 Dec 2015

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.

8 Dec 2015

BioLight announces first sale of IOPtiMate system in Portugal

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate system to a medical center located in Portugal.

8 Dec 2015

Dompé’s investigational biotech molecule receives orphan drug designation for treatment of neurotrophic keratitis

The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth Factor (rhNGF) - the investigational biotech molecule developed by Dompé based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis.

8 Dec 2015

OphthaliX completes patient enrollment in CF101 Phase II trial for treatment of glaucoma

OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today that it has completed patient enrollment for its Phase II trial of CF101 in the treatment of glaucoma.

7 Dec 2015

NIDEK launches TONOREF™ III Auto Ref / Kerato / Tono / Pachymeter

NIDEK CO., LTD., a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment, is pleased to announce the launch of the TONOREF™ III Auto Ref / Kerato / Tono /Pachymeter.

From NIDEK CO., LTD. 1 Dec 2015

Johns Hopkins researchers develop method to turn stem cells into retinal ganglion cells

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. Death and dysfunction of these cells cause vision loss in conditions like glaucoma and multiple sclerosis.

1 Dec 2015

Air evacuations may pose significant added risk to patients with traumatic brain injury

Over the past 15 years, more than 330,000 U.S. soldiers have suffered a traumatic brain injury (TBI). It is one of the leading causes of death and disability connected to the country's recent conflicts in Afghanistan and Iraq. Many of these patients were evacuated by air from these countries to Europe and the U.S. for further treatment. In general, these patients were flown quickly to hospitals outside the battle zone, where more extensive treatment was available.

1 Dec 2015

Six-month markers predict long-term cGVHD outcomes

Researchers have identified measures early in the course of chronic graft-versus-host disease that predict long-term prognosis in haematopoietic cell transplantation recipients.

27 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.

25 Nov 2015

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax Laboratories, Inc. today announced that the European Commission has granted marketing authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease.

25 Nov 2015

People with chronic fatigue syndrome could experience higher levels of visual stress

People suffering from Chronic Fatigue Syndrome (CFS) could experience higher levels of visual stress than those without the condition, according to new research from the University of Leicester.

25 Nov 2015

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have discovered a key mechanism by which radiation treatment (radiotherapy) fails to completely destroy tumors. And, in the journal Nature Immunology, they offer a novel solution to promote successful radiotherapy for the millions of cancer patients who are treated with it.

25 Nov 2015

Study identifies amblyopia as key factor for poor reading in school-age children

Children with amblyopia, commonly known as "lazy eye," may have impaired ocular motor function. This can result in difficulties in activities for which sequential eye movements are important, such as reading.

23 Nov 2015

Eye Health News and Research

Latest Eye Health News and Research

Researchers identify brain processes in mice that shape different sensory perceptions

New portable sensor can measure vitamin C levels in fluids that leak from the eye

Biotypes can identify distinct subgroups of psychosis

Adverse environmental changes present potential health hazards to eyes

Groundbreaking study establishes empirical biomarkers to aid in diagnosis, treatment of psychosis

UHCO's Pat Segu earns prestigious distinguished service award in vision care

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

BioLight announces first sale of IOPtiMate system in Portugal

Dompé’s investigational biotech molecule receives orphan drug designation for treatment of neurotrophic keratitis

OphthaliX completes patient enrollment in CF101 Phase II trial for treatment of glaucoma

NIDEK launches TONOREF™ III Auto Ref / Kerato / Tono / Pachymeter

Johns Hopkins researchers develop method to turn stem cells into retinal ganglion cells

Air evacuations may pose significant added risk to patients with traumatic brain injury

Six-month markers predict long-term cGVHD outcomes

Can-Fite BioPharma reports financial results, provides updates on drug development programs

BioLight signs joint financing agreement with two Asia-based venture capital firms

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

People with chronic fatigue syndrome could experience higher levels of visual stress

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Study identifies amblyopia as key factor for poor reading in school-age children

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Eye Health News and Research

Latest Eye Health News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in